ASH-BSH Abstract Achievement Award
The following individuals received the ASH-BSH Abstract Achievement Award, which is part of the National Partner Society Abstract Achievement Awards program.
2025
Giulia Simini
Cancer Institute - University College London
Decoding Transgene Silencing from Stably Maintained AAV Genomes in Human Liver: Epigenetic Insights to Guide Next-Generation Vector Design
Aditya Tedjaseputra
King's College London
FLT3-ITD NGS-MRD refines risk stratification in NPM1 and FLT3 co-mutated AML beyond NPM1 PCR-MRD: Analysis of the UK NCRI AML17 and AML19 trials
Phuong To
Queen Mary University of London, Barts Cancer Institute
Investigating ribosome biogenesis in AML identifies MYB-binding protein 1A (MYBBP1A) as an essential regulator of leukemia cells
2024
Alexandros Rampotas, MBBS, MRCP
University College London
Development of a First-in-Class CAR-T Therapy Against Calreticulin-Mutant Neoplasms and Evaluation in the Relevant Human Tissue Environment
Aneta Mikulasova, PhD
Faculty of Medical Sciences, Newcastle University
Multiomics Data Integration in the Complete Myeloma Genome Reveals Frequent Centromeric Rearrangements and Their Epigenomic Consequences
Xuesen Zheng, PhD
King's College London
Clonal Haematopoiesis with TP53 Mutations Exhibits Abnormal Erythropoiesis and Erythroid Metabolic Stress
2023
I-Jun Lau, DPhil, BMBCh
University of Oxford, United Kingdom
Sustained MYB Activity Is Necessary for Oncogenic Transcription in KMT2A-Rearranged Acute Lymphoblastic Leukemia through Enhancer-Promoter Interactions and Epigenetic Modifications at Enhancers
Maryam Subhan
University College London, United Kingdom
Comparing the Impact of Rituximab Dosing on Longitudinal ADAMTS13 Parameters in TTP
Nikolaos Sousos, MD, MSc, PGCert, DPhil
Oxford University Hospitals, United Kingdom
Platelet-Restricted Clonal Hematopoiesis
2022
Niels Asger Jakobsen, BM BCh, MRCP
University of Oxford
Single-Cell Analysis of Human Clonal Hematopoiesis Identifies Distinct Impact of DNMT3A and TET2 mutations on Hematopoietic Differentiation
Anna Santarsieri, MBBS
Cambridge University Hospitals NHS Foundation Trust
Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy
Shuchi Agrawal Singh, PhD
Cambridge Institute for Medical Research, Cambridge Biomedical Campus
HOXA9 Nucleates a Repressive Chromatin Complex with Nuclear Matrix-Associated Protein- Safb to Maintain Acute Myeloid Leukemia
2021
Emily Mitchell
Wellcome Sanger Institute
Clonal Dynamics of Normal Haematopoiesis with Human Ageing
Abstract #598
Matthew Wilson
Beatson West of Scotland Cancer Centre
Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treatment Delivery: A Multicentre International Analysis of 1384 Patients
Abstract #452
Mohsin Badat, MB, Bchir
University of Oxford
Base Editing Repairs the HbE Mutation Restoring the Production of Normal Globin Chains in Severe HbE/β-Thalassemia Patient Hematopoietic Stem Cells and Erythroid Cells
Abstract #2935
2020
Deena Iskander, MD
Imperial College London
Single-Cell Transcriptional Landscapes of Human Bone Marrow Reveal Distinct Erythroid Phenotypes Underpinned By Genotype in Diamond-Blackfan Anemia
Abstract #2749
Jayna Mistry, BSc
The University of East Anglia
Enhanced Free Fatty Acid Uptake Via CD36 Promotes a Metabolic Switch to B-Oxidation within Hematopoietic Stem Cells in Response to Acute Infection
Abstract #451
Rebecca Shaw, MBChB
University of Liverpool
Circulating Histone Levels Correlate with the Severity of COVID-19 and the Extent of Coagulation Activation and Inflammation
Abstract #1773
2019
Konstantinos Tzelepis, PhD
University of Cambridge
Pharmacological Inhibition of the RNA m6a Writer METTL3 As a Novel Therapeutic Strategy for Acute Myeloid Leukemia
Abstract #403
Claire Burney, MBBS
University Hospitals Bristol
Ibrutinib for Relapsed Mantle Cell Lymphoma after Standard First Line Therapy and ASCT Is Efficacious but Does Not Overcome the Impact of POD24 – a Retrospective Study from the LWP-EBMT
Abstract #701
Sam Alimam, DHSc, MD
King's College
Molecular, Epigenetic and Gene Expression Profiling of Triple Negative Essential Thrombocythaemia
Abstract #308